Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies

BACKGROUND: Treatment of advanced melanoma has been improved with the advent of the BRAF inhibitors. However, a limitation to such treatment is the occurrence of resistance. Several mechanisms have been identified to be responsible for the development of resistance, either MEK-dependent or MEK-indep...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fattore, Luigi, Marra, Emanuele, Pisanu, Maria Elena, Noto, Alessia, de Vitis, Claudia, Belleudi, Francesca, Aurisicchio, Luigi, Mancini, Rita, Torrisi, Maria Rosaria, Ascierto, Paolo Antonio, Ciliberto, Gennaro
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3729364/
https://ncbi.nlm.nih.gov/pubmed/23890105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-180
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items